drugset / Trial / NCT04200989

Novel Treatment for Patients With Peanut Allergy: Intralymphatic Immunotherapy

NCT04200989 ↗

NaSingle-groupOpen-labelTreatment

Summary

Use of three intralymphatic injections of peanut allergen one month apart to induce tolerance to peanut in peanut allergic people.

Timeline

Start
2021-03-01
Primary completion
2021-12-31
Completion
2021-12-31

Outcome

Outcome not reported

Stopped (Business): “Lack of funding”

Drugs

EvaluationDrugModalityDoseRoute
Subject Peanut allergen Unknown — Other

Indications